Optimized preparation of poly d,l (lactic-glycolic) microspheres and nanoparticles for oral administration
Authors:
- M. ChacónMCM. Chacón
- L. BergesLBL. Berges
- J. MolpeceresJMJ. Molpeceres
- M.R. AberturasMAM.R. Aberturas
- M. GuzmanMGM. Guzman
- 1 September 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 141 (1-2) , 81-91
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporinInternational Journal of Pharmaceutics, 1995
- Optimization of pharmaceutical formulations based on response-surface experimental designsInternational Journal of Pharmaceutics, 1993
- Formation and Characterization of Cyclosporine-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1993
- Reduced kallikrein excretion by liposome-encapsulated cyclosporin in the ratJournal of Pharmacy and Pharmacology, 1993
- Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patchesJournal of Controlled Release, 1990
- Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticlesJournal of Microencapsulation, 1990
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989
- Liposomal Formulation Eliminates Acute Toxicity and Pump Incompatibility of Parenteral CyclosporinePharmaceutical Research, 1989
- The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation MethodPharmaceutical Research, 1987
- Evaluation of carrier capacity and release characteristics for poly( butyl 2-cyanoacrylate) nanoparticlesInternational Journal of Pharmaceutics, 1986